With its latest obesity play appearing to pay off, Regeneron has turned its attention to radiopharmaceuticals.
- Home |
- Regeneron rides into radiopharma via $2.1B biobucks pact with Australia’s Telix
Regeneron rides into radiopharma via $2.1B biobucks pact with Australia’s Telix
- April 13, 2026
Recent Posts
- Oil jumps 5% as Hormuz tanker attacks escalate, US Gulf hurricane shuts in production
- Crescent Energy to acquire Eagle Ford assets from Devon for $4.2 billion
- LNG market tightens into winter as Europe pulls US cargoes, China reopens contract talks
- EIA: US crude oil inventories down 3.2 million bbl
- Chevron restructures Bakken midstream agreements, transfers Hess Midstream stake
